The online version of this article (doi:10.1007/s00520-016-3456-z) contains supplementary material, which is available to authorized users.
This study investigated the short- and long-term use of medication for psychological distress after the diagnosis of cancer.
Longitudinal data from the Taiwan National Health Insurance database were used to follow 35,137 cancer patients for 2.5 years after being diagnosed in 2006 and 2007.
Among those patients who survived for at least 180 days, 20.9 % had used psychotropic medications; sedatives were the most frequently prescribed (14.3 %), followed by antidepressants (5.5 %), anxiolytics (3.6 %), and antipsychotics (2.7 %). Lung cancer, prostate cancer, and oral cancer showed a significant association with the regular use of medication in the first 180 days. Among patients who survived for at least 2.5 years, 4.8 % still used psychotropic medication on a regular basis. Lung cancer and prostate cancer were associated with such prolonged use.
This longitudinal study found that the type of cancer was significantly associated with the use of psychotropic drugs after the diagnosis was made. It provided information about the trajectory of that use and found that a small number of patients were still using those medications after 2.5 years.
Ng CG, Boks MP, Smeets HM, Zainal NZ, deWit NJ (2009) Prescription patterns for psychotropic drugs in cancer patients: a large population study in the Netherlands. Psychooncology 22:762–767 CrossRef
Greer JA, Solis JM, Temel JS et al (2012) Anxiety disorders in long-term survivors of adult cancers. Psychosomatics 53:68–74 CrossRef
Lund LW, Winther JF, Cederkvist L et al (2015) Increased risk of antidepressant use in childhood cancer survivors: a Danish population-based cohort study. Eur J Cancer 51:674–684 CrossRef
The Taiwan National Health Research Institutes. Report of Findings from the 2005 Taiwan National Health Interview Survey, No. 1. Available: http://nhis.nhri.org.tw/files/2005NHIS_Final%20Report_1.pdf. Accessed 16 Oct 2015
National Comprehensive Cancer Network. NCCN Guidelines for Supportive Care. Available: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#supportive. Accessed 1 Apr 2016
Sikka R, Xia F, Aubert RE (2005) Estimating medication persistency using administrative claims data. Am J Manag Care 11:449–457 PubMed
Li L-A (2004) A study on the order of the degree of urbanisation among the Lo Chi-Hon Strata of Taiwan counties. Surv Res Method Appl 15:5–30
Epstein JF, Induni M, Wilson T (2009) Patterns of clinically significant symtoms of depression among heavy users of alcohol and cigarettes. Prev Chronic Dis 6:A09 PubMed
Hammerlid E, Ahlner-Elmqvist M, Bjordak K et al (1999) A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients. Br J Cancer 80(5e6):766e74
Dinh KT, Reznor G, Muralidhar V, et al. (2016) Association of androgen deprivation therapy with depression in localized prostate cancer. p.JC0641969.
- Short- and long-term use of medication for psychological distress after the diagnosis of cancer
Lynn Chu Huang
- Springer Berlin Heidelberg
Neu im Fachgebiet Onkologie
Mail Icon II